Skip to main content

IMM Investment — Portfolio, Page 5

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

145
Companies
$2.7B
Total invested
$27.5M
Avg. check
46
Industries
Biotechnology 9Medical 6Pharmaceutical 6Artificial Intelligence (AI) 5Health Care 5Biopharma 5+40 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 97120 of 145
TeamFresh
June 2022

TeamFresh is a cargo and freight company that provides logistics services.

Freight Service · Songpadong$123.8M Series D
LumanLab
June 2022

LumanLab develops digital therapeutics to solve developmental delay problems.

Health Diagnostics · Seoul$2.4M Seed
UPPTHERA
May 2022

UPPTHERA is a pharmaceutical company that specializes in drug development using targeted protein degradation technology.

Medical · Incheon$21.9M Series B
Westworld
May 2022

Westworld is a visual effects company that offers VFX, virtual production, and previsualization services for film production.

Animation · Koyang$15.6M Series A
CN AI
April 2022

CN AI provides consulting services using AI.

Artificial Intelligence (AI) · Seoul$4.0M Seed
Oncorus
April 2022

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

Biotechnology · Cambridge$20.0M Post Ipo Debt
Spark Biopharma
April 2022

Spark Biopharma is a biotechnology company

Biotechnology · Seoul$20.6M Series C
Kobiolabs
March 2022

Kobiolabs is a microbiome-based venture

Biopharma · Seongnam$8.3M Series Unknown
Selecxine
March 2022

Selecxine is a biopharmaceutical development company specialized in the field of immunotherapeutics.

Biopharma · Songpadong$27.3M Series B
Encina
March 2022

Encina provides technology solutions to develop renewable products from plastic waste.

Chemical · The Woodlands$55.0M Series Unknown
BIORCHESTRA
February 2022

BIORCHESTRA creates novel RNA-based therapeutics that will usher in a new era of treatment for neurodegenerative diseases.

Biopharma · Yusong$45.7M Series C
Curocell
January 2022

Curocell’s OVIS™ technology enhances immune cells to overcome immune suppression in tumor microenvironments.

Biopharma · Daejeon$30.1M Series Unknown
Unlimeat
November 2021

Unlimeat is plant-based meat for the planet and to create a virtuous circle in the food industry.

Alternative Protein · Seocho$6.7M Debt Financing
Teoul
November 2021

Teoul is a digital healthcare management company that offers solutions for pharmacists to provide professional and easy medication guidance.

Health Care · Seoul$1.3M Seed
Crowdworks
November 2021

Crowdworks solves the toughest problem in AI today: Delivering training data sets with next-level accuracy, quality assured.

Artificial Intelligence (AI) · Seoul$13.4M Series C
ExoStemTech
October 2021

ExoStemTech is a biotechnology company that develops stem cell exosome therapeutics, plant exosomes, and anti-cancer drugs.

Biotechnology · Ansan$8.6M Series B
Dohands
September 2021

Dohands provides customized logistics services.

Logistics · Yeoksamdong$18.5M Series B
Timee
August 2021

Timee is a gig working platform that offers the necessary infrastructure to address management challenges.

B2B · TokyoSeries Unknown
Motion2AI
August 2021

AI-powered Forklift Telematics and Forklift Tracking to prevent accidents and improve utilization.

Artificial Intelligence (AI) · Dallas$12.6M Series A
Connecting
August 2021

Connecting is a real-time voice-talk service company that connects people with the right conversation code.

Audio · Seoul$9.1M Series B
DeepMetrics
July 2021

DeepMetrics is an AI driven ICU automation platform company

Artificial Intelligence (AI) · Seoul$1.3M Seed
SCAI Therapeutics
July 2021

SCAI Therapeutics is a drug delivery platform bio-venture company for pharmaceutical industry.

Biotechnology · Daejeon$27.5M Series B
J2H Biotech
July 2021

J2H Biotech is a bio-venture company focusing on the development of small-molecule drugs for the treatment of intractable rare diseases.

Biopharma · Seongnam$26.2M Series Unknown
Ground
June 2021

Ground is a logistics tech company that provides with advanced tech such as AI, robotics solution, logistics consulting and GWES services.

Artificial Intelligence (AI) · Koto$4.5M Corporate Round

Where IMM Investment invests

Biotechnology9
Medical6
Pharmaceutical6
Artificial Intelligence (AI)5
Health Care5
Biopharma5

About IMM Investment's portfolio

How many companies has IMM Investment invested in?

IMM Investment has invested in 145 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does IMM Investment invest in?

IMM Investment's top investment sectors include Biotechnology, Medical, Pharmaceutical, Artificial Intelligence (AI), Health Care. The firm invests across 46 different industry categories.

What is IMM Investment's largest investment?

Among tracked funding rounds, TeamFresh received $123.8M in a Series D round. IMM Investment's total known invested capital is $2.7B.

What is the average investment size for IMM Investment?

IMM Investment's average investment size is $27.5M across its portfolio of 145 companies.

What are IMM Investment's most recent investments?

Recent IMM Investment portfolio additions include TeamFresh, LumanLab, UPPTHERA, Westworld, CN AI. These companies were founded in 2020 or later.

Reach the founders behind these 145 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →